Matthew M. Schuckmann
FDA Investigator
- Matthew M. Schuckmann first started conducting FDA inspections in 2020, with the last inspection in 2024. Over that time, Matthew M. Schuckmann has conducted 27 inspections at 24 companies across 22 sites.
Get Matthew Schuckmann's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Marcus Research Laboratory, Inc., St. Louis | 2024
Out of stock
FDA 483 POINT Biopharma USA Inc, Indianapolis | 2024
Out of stock
FDA 483 R.D. Laboratories Inc., Washington | 2024
Out of stock
FDA 483 Huvepharma Inc, Saint Louis | 2023
Out of stock
FDA 483 EKG Life Science Solutions, Saint Louis | 2021
Out of stock
FDA 483 Missouri Analytical Laboratories, Inc., St. Louis | 2021
Out of stock
Co-Investigators (23)
- Aerial A. Smith, FDA Investigator
- Muna Algharibeh, FDA Investigator
- Jacob G. Lutz, FDA Investigator
- Beatrix D. Arevalo, FDA Investigator
- Beatrix D. Hippe, FDA Investigator
- Melissa M. Steiger, FDA Investigator
- Chad W. Rice, FDA Investigator
- Damaris Y. Hernandez, FDA Investigator
- Monica E. Murie, FDA Investigator
- Michael C. Zubelewicz, FDA Investigator
- Norman K. Starks, FDA Investigator
- Logan T. Williams, FDA Investigator
- Robert J. Ham, FDA Investigator
- Matthew B. Casale, FDA Investigator
- Carl A. Huffman, FDA Investigator
- Torrey M. Ward, FDA Investigator
- Vikas Moolchandani, FDA Investigator
- Derrionna M. Epps, FDA Investigator
- Wayne D. McGrath, FDA Investigator
- Shanna R. Haden, FDA Investigator
- Sri Rama Yellela, FDA Investigator
- Victoria P. Quadrini, FDA Investigator
- Yellela, Sri Rama Kr, FDA Investigator